Business Segments Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.09 CNY | +19.99% | +19.99% | +20.67% |
26/08 | Aier Eye Hospital Group H1 Profit Up 20%, Operating Income Rises 3% | MT |
23/08 | Aier Eye Hospital Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Hospitals and Healthcare Centers | ||||||||||
Medical Industry | 997.39Cr | 1.19TCr | 1.5TCr | 1.61TCr | 2.03TCr | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Unallocated Other Business | 1.62Cr | 1.23Cr | 2.79Cr | 4.11Cr | 5.43Cr | |||||
Other | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Optician Service | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Medicine | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Health Care Service | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Central China | 349.78Cr | 386.9Cr | 473.14Cr | 606.35Cr | 552.82Cr | |||||
Total Assets | 1.42TCr | 1.96TCr | 2.35TCr | 3.16TCr | 3.41TCr | |||||
Interest Expense | -3.37Cr | -5.71Cr | -5.18Cr | -7.5Cr | -6.8Cr | |||||
D&A | 21Cr | 22Cr | 37Cr | 45Cr | 39Cr | |||||
CAPEX | -55Cr | -8.61Cr | -91Cr | -72Cr | - | |||||
EBT | 227.37Cr | 309.54Cr | 319.96Cr | 450.61Cr | 429.06Cr | |||||
Unallocated Amount | 157.33Cr | 192.56Cr | 253.03Cr | 270.93Cr | 359.22Cr | |||||
Interest Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
East China | 118.27Cr | 158.92Cr | 208.09Cr | 230.79Cr | 311.38Cr | |||||
Total Assets | 62Cr | 102.92Cr | 190.24Cr | 295.75Cr | 369.89Cr | |||||
Interest Expense | - | - | -2.21Cr | -2.75Cr | -3.19Cr | |||||
D&A | 6.05Cr | 8.22Cr | 18Cr | 31Cr | 31Cr | |||||
CAPEX | -10Cr | -13Cr | -84Cr | -69Cr | - | |||||
EBT | 9.91Cr | 22Cr | 22Cr | 18Cr | 31Cr | |||||
South China | 105.83Cr | 145.54Cr | 186.02Cr | 213.11Cr | 259.73Cr | |||||
Total Assets | 71Cr | 123.95Cr | 183.86Cr | 203.02Cr | 275.25Cr | |||||
Interest Expense | - | - | -2.17Cr | -2.36Cr | -2.99Cr | |||||
D&A | 5.32Cr | 6.05Cr | 13Cr | 15Cr | 19Cr | |||||
CAPEX | -5.54Cr | -10Cr | -50Cr | -12Cr | - | |||||
EBT | 21Cr | 34Cr | 39Cr | 45Cr | 52Cr | |||||
Southwest Region | 137.05Cr | 160.81Cr | 195.6Cr | 200.46Cr | 258.54Cr | |||||
Total Assets | 93Cr | 129.32Cr | 235.37Cr | 254.41Cr | 305.18Cr | |||||
Interest Expense | - | -1L | -3.5Cr | -3.61Cr | -3.76Cr | |||||
D&A | 4.79Cr | 6.16Cr | 17Cr | 17Cr | 22Cr | |||||
CAPEX | -9.2Cr | -11Cr | -91Cr | -13Cr | - | |||||
EBT | 26Cr | 33Cr | 32Cr | 30Cr | 41Cr | |||||
Northeast China | 78Cr | 92Cr | 110.61Cr | - | 179.42Cr | |||||
Total Assets | 51Cr | 65Cr | 106.88Cr | - | 189.22Cr | |||||
Interest Expense | - | - | -87.76L | - | -1.16Cr | |||||
D&A | 3.54Cr | 3.72Cr | 7.26Cr | - | 14Cr | |||||
CAPEX | -2.83Cr | -7.51Cr | -43Cr | - | - | |||||
EBT | 11Cr | 20Cr | 23Cr | - | 36Cr | |||||
Europe | 96Cr | 95Cr | 131.95Cr | 141.05Cr | 172.04Cr | |||||
Total Assets | 174.75Cr | 186.17Cr | 203.85Cr | 227.79Cr | 257.08Cr | |||||
Interest Expense | -1.51Cr | -1.69Cr | -71.57L | -42.15L | -92.25L | |||||
D&A | 4.8Cr | 3.16Cr | 9.46Cr | 9.37Cr | 16Cr | |||||
CAPEX | -1.63Cr | -16Cr | -19Cr | -11Cr | - | |||||
EBT | 8.84Cr | 12Cr | 28Cr | 38Cr | 37Cr | |||||
Northern China | 71Cr | 79Cr | 106.43Cr | 116.91Cr | 156.52Cr | |||||
Total Assets | 39Cr | 62Cr | 98Cr | 115.78Cr | 127.37Cr | |||||
Interest Expense | - | - | -1.25Cr | -1.28Cr | -1.59Cr | |||||
D&A | 2.47Cr | 2.63Cr | 8.6Cr | 10Cr | 13Cr | |||||
CAPEX | -74.67L | -8.89Cr | -35Cr | -16Cr | - | |||||
EBT | 8.44Cr | 10Cr | 15Cr | 12Cr | 20Cr | |||||
North-West Region | 22Cr | 35Cr | 49Cr | 50Cr | 87Cr | |||||
Total Assets | 16Cr | 33Cr | 46Cr | 67Cr | 95Cr | |||||
Interest Expense | - | - | -35.11L | -49.31L | -1.12Cr | |||||
D&A | 1.37Cr | 1.75Cr | 3.84Cr | 5.34Cr | 8.09Cr | |||||
CAPEX | 59.58L | -5.7Cr | -8.3Cr | -8.53Cr | - | |||||
EBT | 1.57Cr | 4.35Cr | 5.63Cr | 2.2Cr | 9.8Cr | |||||
Southeast Asia | - | 18Cr | 20Cr | 31Cr | 37Cr | |||||
Total Assets | 75Cr | 49Cr | 49Cr | 74Cr | 60Cr | |||||
Interest Expense | -22.17L | -1.23Cr | -82.7L | -25.69L | -5L | |||||
D&A | - | 1.41Cr | 2.94Cr | 1.73Cr | 2.26Cr | |||||
CAPEX | -53Cr | 24Cr | -66.67L | -12Cr | - | |||||
EBT | -57.93L | -27Cr | 3.12Cr | 8.68Cr | 8.85Cr | |||||
Hong Kong | 15Cr | 14Cr | 14Cr | 16Cr | 17Cr | |||||
Total Assets | 31Cr | 27Cr | 37Cr | 134.34Cr | 49Cr | |||||
Interest Expense | -68.77L | -4L | -6L | -2L | -6L | |||||
D&A | 2.57Cr | 93.01L | 2.35Cr | 3.09Cr | 2.44Cr | |||||
CAPEX | 13Cr | -42.72L | 2.1Cr | -7L | - | |||||
EBT | -12Cr | -8.18Cr | 2.34Cr | 5.25Cr | 4.04Cr | |||||
United States | 6.05Cr | 5.25Cr | 5.79Cr | 5.85Cr | 4.87Cr | |||||
Total Assets | 10Cr | 8.25Cr | 11Cr | 22Cr | 8.65Cr | |||||
Interest Expense | -43.54L | -25.9L | -2L | -2L | -2L | |||||
D&A | 20.03L | 13.71L | 18.71L | 18.19L | 30.95L | |||||
CAPEX | -3L | 2.44Cr | -1.74Cr | -19.24L | - | |||||
EBT | 1.1Cr | -1.26Cr | 1.88Cr | 2.17Cr | -3.95Cr | |||||
Corporate | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
China | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Intersegment Elimination | -157.33Cr | -192.56Cr | -253.03Cr | -270.93Cr | -359.22Cr | |||||
Total Assets | -854.32Cr | -1.19TCr | -1.33TCr | -1.89TCr | -2.13TCr | |||||
Interest Expense | - | 1.4Cr | 14.34L | 94.84L | 2.2Cr | |||||
D&A | -1.52Cr | -68.12L | -6.3Cr | - | - | |||||
CAPEX | -21Cr | -147.41Cr | -52Cr | -14Cr | - | |||||
EBT | -118.61Cr | -172.67Cr | -185.01Cr | -278.23Cr | -209.19Cr |
- Stock Market
- Equities
- 300015 Stock
- Financials Aier Eye Hospital Group Co., Ltd.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition